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ABSTRACT
Background: Non-pharmacological interventions for Behavioral and Psychological Symptoms of Dementia
(BPSD) have been developed; however, a systematic review on the effectiveness of this type of intervention
from a perspective of ergonomics is lacking. According to ergonomics, the capabilities of Persons with
Dementia (PwD) should be considered in the interventions for the outcomes to be reliable. We aimed to
systematically review the non-pharmacological interventions for BPSD in nursing home residents with an
additional assessment criterion based on ergonomics, speciﬁcally, capability consideration.
Methods: The electronic databases MEDLINE, EMBASE, and PsycINFO were searched for non-
pharmacological interventions treating BPSD in nursing homes. The interventions were categorized according
to the capabilities of PwD required to participate. Study quality was assessed by National Health and Medical
Research Council (NHMRC) evidence hierarchy and the capability consideration.
Results: Sixty-four clinical trials met the inclusion criteria; 41 trials reported a signiﬁcant reduction in at least
one BPSD symptom; 20 trials reported no signiﬁcant reduction in BPSD symptoms; three trials reported
adverse effects after the intervention. Interventions were categorized into sensory-, cognition-, and movement-
oriented. Capabilities of PwD were not considered in 28 trials, especially for sensory capabilities.
Conclusions: Themajority of the clinical trials reported a signiﬁcant reduction in BPSD. The quality of evidence
for nonpharmacological interventions in these trials is low due to the lack of capability consideration, data
inhomogeneity, and inadequate study design and reporting. Future studies should focus on improving the
quality of evidence by including capability consideration and examining if a relationship between capability
consideration and effectiveness of non-pharmacological interventions exists.
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Introduction
Over 80% of Persons with Dementia (PwD) will
develop Behavioral and Psychological Symptoms of
Dementia (BPSD), also referred to as neuropsychi-
atric symptoms, during the course of their disease
(Abraha et al., 2017), with 97% of PwDdeveloping at
least one symptom over a ﬁve-year period (Steinberg
et al., 2008). BPSD is deﬁned as “signs and symp-
toms of disturbed behavior, mood, thought, or per-
ception” (Kales et al., 2015). The Neuropsychiatric
Inventory–Questionnaire (NPI-Q) has categorized
the reported signs and symptoms into: delusions,
hallucinations, agitation/aggression, depression/
dysphoria, anxiety, elation/euphoria, apathy/indif-
ference, disinhibition, irritability/lability, motor
disturbance, nighttime behaviors, and disturbance
in appetite/eating (Kaufer et al., 2000). BPSD
could induce physical injuries and psychological
distress in PwD and their caregivers, and it is
identiﬁed as a predictor of nursing home placement
(Gaugler et al., 2003). In nursing homes, caregivers
have reported to respond to PwD exhibiting BPSD
with verbal or physical abuse or tominimize contact
with them, thus reducing the quality of care
received by PwD (Kales et al., 2015). Nursing
home administrators could face increased ﬁnancial
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costs due to increased medical and psychological
care, security concerns, and staff turnover (Kales
et al., 2015). Therefore, effective management of
BPSD needs to be identiﬁed and applied, especially
in the nursing home setting.
Antipsychotic medication has been applied to
manage BPSD, which has been shown to have
low efﬁcacy and serious side effects, such as increas-
ing fall risk, mortality rate, and stroke occurrence
(Gill et al., 2007; Seppala et al., 2018). As a result,
non-pharmacological interventions have been devel-
oped to act as an alternative of antipsychotic medi-
cation. This study proposes a hypothesis that new
insights could be gained if the non-pharmacological
interventions and their clinical trials are also reviewed
and assessed from a perspective of ergonomics. Ergo-
nomics studies “the interactions between humans
and other elements of a system, and applies theories,
principles, data, and methods to design for optimiz-
ing human well-being and system performance”
(Karwowski, 2012). Human performance depends
on the person’s capabilities and limitations; while
the system has its own requirements and affor-
dances. These requirements and affordances need
to match with the capabilities and limitations of
the target population for the outcome of the system
to be reliable. From an ergonomist’s view, non-
pharmacological interventions could be regarded
as the system. The remaining capabilities of PwD
and the requirements of the interventions should
match for the outcome of the clinical trial to be
reliable. Capability is an umbrella term used in
ergonomics to describe one’s ability in sensory,
cognition, and movement aspects when interacting
with a system (Czaja and Nair, 2006). One needs
certain levels of capabilities to be able to perform
certain cognitive and functional activities, namely
Activities of Daily Living (ADL) or Instrumental
Activities of Daily Living (IADL).
Several systematic reviews have reviewed and
assessed the quality of the clinical trials to conclude
on the quality of evidence on the effectiveness for
each intervention. Abraha et al. found that music
therapy and behavioral management techniques are
effective in managing BPSD, in general, while the
evidence base is weak due to variations in applica-
tion of the interventions andmeasurements (Abraha
et al., 2017). Brasure et al. reached the same con-
clusion on the weak evidence base after systemati-
cally reviewing non-pharmacological interventions
in managing agitation and aggression in PwD
(Brasure et al., 2016). Cohen-Mansﬁeld identi-
ﬁed that many non-pharmacological interventions
have led to a statistically and clinically meaningful
improvement in the management of behavioral
problems, and stated that the variation in criteria
for success, screening procedures, and control
procedures together with underreported treatment
failures prevent further conclusions to be drawn
(Cohen-Mansﬁeld, 2001). A meta-analysis showed
that non-pharmacological interventions delivered by
family caregivers had an effect size in managing
BPSD at least equaling that of antipsychotic medica-
tion (Brodaty and Arasaratnam, 2012). However,
as the focus of the current review is on capability
considerations of PwD when they are interacting
with non-pharmacological interventions, caregiver
interventions are not included in this review as
caregiver interventions do not require capabilities
of PwD.
The systematic reviews currently available in
the literature have evaluated neither the non-
pharmacological interventions nor their clinical trials
based on the abovementioned capability matching
principle in ergonomics. Speciﬁcally, these reviews
have not assessed if capabilities of PwD were con-
sidered in the non-pharmacological interventions
and their clinical trials (Abraha et al., 2017; Brasure
et al., 2016; Cohen-Mansﬁeld, 2001). In addition,
the availability of resources, severity of cognitive
impairment, and levels of comorbidity are different
in community and nursing home settings. However,
no systematic review on non-pharmacological inter-
ventions for BPSD has distinguished between inter-
ventions in community settings and nursing home
settings. A systematic review on the effectiveness of
non-pharmacological interventions for BPSD in
nursing home residents is also lacking. Therefore,
this study aims to systematically review the non-
pharmacological interventions for BPSD in nursing
home residents, with a special focus on capability
considerations as recommended in ergonomics.
Methods
Search strategy
The literature search was performed in three
electronic databases: PsycINFO, EMBASE, and
MEDLINE. For the searches, the following sets of
search terms were used: (1) dementia, (2) BPSD,
and (3) nursing home, with the searches limited to
therapy (maximize sensitivity). The ﬁrst set of terms
included “dementia (exploded)”, “dementi*”,
“Alzheimer*”. The second set of terms consisted
of “neuropsych*”, “behav*”, “behav* problems
(exploded)”. The third set of terms involved “nurs-
ing home (exploded)”, “nursing care”. The date of
the last search is January 8, 2018. The full search
strategy is listed in the supplemental digital con-
tent (SDC) -1 (published as supplementary mate-
rial online attached to the electronic version of this
paper at https://www.cambridge.org/core/journals/
international-psychogeriatrics).
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Inclusion criteria
Inclusion criteria for studies relevant for this review
were: (1) studies that involved nursing home resi-
dents with a diagnosis of dementia; (2) studies that
applied non-pharmacological interventions for BPSD
which require capabilities of nursing home residents;
(3) studies that reported on effects of the interventions
on symptoms of BPSD; (4) studies with a pre-post,
(quasi) experimental, cross-sectional, randomized
controlled, or longitudinal design; and (5) studies
written in English and published in a peer-reviewed
journal between January 1, 1998 and January 1, 2018.
Intervention categorization
The interventions were categorized according to the
capabilities of PwD required to participate. Ergo-
nomics has investigated human capabilities and how
these capabilities change with age. The age-related
capabilities investigatedwere in terms of the sensory,
cognition, and movement aspects (Freudenthal,
1999). As the majority of PwD are over the age of
65, they suffer from capability declines in these three
aspects not only due to dementia, but also age.
Therefore, the interventions were categorized into
sensory-, cognition-, andmovement-oriented in this
review.
Quality assessment
We evaluated the quality of each trial based on
the National Health and Medical Research Council
(NHMRC) evidence hierarchy (NHMRC, 2000).
In addition, each trial was judged for whether
capabilities of PwD were considered. Two criteria
were used in this review for rating “capability
consideration.” First, we assessed if the intervention
investigated in the trial had been designed with the
capabilities of PwD in mind; that is, if design guide-
lines for PwD had been incorporated or PwD had
been involved in the design process. When the ﬁrst
criterion was not satisﬁed, we assessed if the trial
only included PwD with adequate capabilities
required by the intervention. For example, if PwD
with hearing impairments were excluded from a
clinical trial on Music Therapy. The clinical trial
was rated “Yes” for “capability consideration,” if it
satisﬁed either criterion, and rated “No” when both
criteria were not met.
Results
The study selection process, guided by Preferred
Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA), is shown in Figure 1. The search
disclosed 2295 abstracts, of which 101 clinical trials
were chosen as potentially relevant; of these, 64 trials
met all the inclusion criteria. The summary of the
three intervention categories is shown in Table 1.
More intervention types were categorized as sensory-
oriented, rather than cognition- and movement-
oriented. The summary of intervention outcomes is
shown in Figure 2. Forty-one trials reported a signiﬁ-
cant reduction on at least one BPSD-symptom; 20
trials reported no signiﬁcant reduction while three
trials reported that the BPSD-symptoms worsened
after the intervention. The “capability considera-
tions” of the clinical trials are summarized and shown
in Figure 3. As shown in Figure 3, 28 trials did not
consider the capabilities of PwD. The details of
Figure 1. Flow diagram of the systematic review.
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each trial are listed in the supplemental digital
content (SDC) -2 (published as supplementary
material online attached to the electronic version
of this paper at https://www.cambridge.org/core/
journals/international-psychogeriatrics). The details
include: trial type, patient type, intervention, scores
in NHMRC and “capability consideration,” and
outcomes. Each intervention type is described below
in the sequence of sensory-oriented, cognition-
oriented, and movement-oriented categories, with
the intervention types that were investigated by
only one trial described together as “other interven-
tions” in each category. For trials satisfying the ﬁrst
“capability consideration” criterion (i.e. Snoezelen
Therapy, Technology-Assisted Therapy, Animal-
Assisted Therapy, Clowning Therapy, and Reminis-
cence Therapy), we included the speciﬁc design
guidelines used, or features of the intervention that
had been modiﬁed based on preliminary ﬁeld testing
in the description below.
Sensory-oriented therapy
MUSIC THERAPY
Twenty-one trials investigated the effectiveness of
Music Therapy; 10 trials are of NHMRC evidence
hierarchy II (Clark et al., 1998; Garland et al., 2007;
Guétin et al., 2009; Raglio et al., 2008, 2010a, 2010b;
Remington, 2002; Sung et al., 2006; Thornley
et al., 2016; Tuet and Lam 2006), six trials are of
hierarchy III-1 (Chang et al., 2010; Ledger and
Baker, 2007; Irish et al., 2006; Suzuki et al., 2004,
2007; van de Winckel et al., 2004), two trials are of
hierarchy III-2 (Cooke et al., 2010; Nair et al., 2011),
and three trials are of hierarchy IV (Ashida, 2000;
Ray and Mittelman, 2017; Sung and Chang, 2010).
The delivery approach, music type, content, session
type, duration, frequency of application, and the total
intervention time ofMusic Therapy vary across trials.
The delivery approach can be classiﬁed into
receptive and active. The PwD only listened to
the music in the receptive approach, while the
PwD interacted with the music by singing or playing
with instruments in the active approach. The music
type can be divided into recorded and live. The
contents of themusic used were either genericmusic
or music preferred by PwD. The session type was
either an individual session or a group session. The
duration of music ranged from 10 to 60 minutes in
the trials, which reported duration. The reported
frequency of application varied from once a week to
everyday, and the reported total intervention time
spanned from two weeks to one year.
The outcomes of Music Therapy are mainly posi-
tive. Seventeen trials demonstrated that one or more
BPSD symptoms had reduced signiﬁcantly (Ashida,
2000; Chang et al., 2010; Clark et al., 1998; Cooke
et al., 2010; Garland et al., 2007; Guétin et al.,
2009; Raglio et al., 2008, 2010a, 2010b; Ray and
Mittelman, 2017; Remington, 2002; Sung et al.,
2006; Sung and Chang, 2010; Suzuki et al., 2004,
2007; Tuet and Lam 2006; van de Winckel et al.,
2004). Two trials showed that the change in BPSD
was insigniﬁcant (Irish et al., 2006; Ledger andBaker,
2007), and two trials found that the BPSD symptoms
deteriorated after the intervention (Nair et al., 2011;
Thornley et al., 2016). Only seven trials considered
the auditory capability of the PwD (Chang et al.,
2010; Garland et al., 2007; Ray and Mittelman,
2017; Remington, 2002; Sung et al., 2006; Sung
and Chang, 2010; van de Winckel et al., 2004). One
trial mentioned the music was played “sufﬁcient to
be heard throughout the common area,” but it did
not specify if the music was sufﬁcient to be heard for
the researchers or PwD (Nair et al., 2011). Thus, the
author decided this trial did not consider the hearing
capabilities of PwD.
AROMATHERAPY
Nine trials have investigated the effectiveness of
Aromatherapy; ﬁve trials were of NHMRC evidence
hierarchy II (Akhondzadeh et al., 2003; Ballard et al.,
2002; Fu and Moyle, 2013; Holmes et al., 2002;
Smallwood et al., 2001), one trial was of hierarchy
III-1 (Snow et al., 2004), and three trials were of
hierarchy III-2 (Lin et al., 2007; O’Connor et al.,
2013; Yoshiyama et al., 2015). The delivery app-
roach, formulation, concentration, frequency of
application, duration, and total intervention time
of Aromatherapy varied across trials.
The essential oil was delivered to the PwD thro-
ugh massage, spray, or diffuser. The formulation of
Table 1. Summary of the three intervention categories
for BPSD in nursing home residents according to
capabilities in ergonomics
INTERVENTION
CATEGORIES
INTERVENTION TYPES
(NUMBER OF TRIALS)
............................................................................................................................................................
Sensory-oriented Music Therapy (21)
Aromatherapy (9)
Light Therapy (5)
Technology-Assisted Therapy (5)
Snoezelen Therapy (2)
Positive Image Therapy (1)
Animal-Assisted Therapy (1)
Clowning Therapy (1)
Cognition-oriented Reminiscence Therapy (5)
Simulated Presence Therapy (3)
Cognitive Stimulation Therapy (1)
Storytelling Therapy (1)
Movement-oriented Exercise Therapy (5)
Outdoor Activity Therapy (4)
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essential oil used was either Lavender or Melissa
ofﬁcinalis with concentrations varying from 2% to
100%. The reported frequency of application ranged
from twice daily to three times a week, and the
reported duration ranged from two hours to the
whole night. The reported total intervention time
spanned from ten days to four months.
The outcomes of Aromatherapy are mixed. Four
trials showed the BPSD symptoms were signiﬁcantly
alleviated after the intervention, in which the essential
oil was applied dermally or via a high-concentration
spray (Akhondzadeh et al., 2003; Ballard et al., 2002;
Lin et al., 2007; O’Connor et al., 2013). The remain-
ing ﬁve trials, in which the essential oil was delivered
by spray in low concentration, found no signiﬁcant
reduction in BPSD (Fu and Moyle, 2013; Holmes
et al., 2002; Smallwood et al., 2001; Snow et al., 2004;
Yoshiyama et al., 2015).None of the trials considered
the olfactory capability of PwD.
LIGHT THERAPY
Five trials evaluated the effectiveness of Light
Therapy; three trials were of NHMRC evidence
hierarchy II (Ancoli-Israel et al., 2003; Burns et al.,
2009; Riemersma-van der Lek et al., 2008) and the
other two trials were of hierarchy III-1 (Barrick et al.,
2010; Hickman et al., 2007). The brightness, dura-
tion, and total intervention time of Light Therapy
varied across trials.
The reported brightness of the light ranged from
1000 lux to 10,000 lux in the intervention groups
and 100 lux to 300 lux in the control groups. The
duration of the Light Therapy varied from 120
minutes to a whole day, and the total intervention
time spanned from 10 days to 3.5 years.
The outcomes of Light Therapy are mixed.
The clinical trial with the best experimental design
found that agitation and depressionwere signiﬁcantly
reduced in a follow-up ranging from 0.5 to 3.5 years.
In this trial, bright light was applied for the whole day
with or without melatonin in the intervention group,
and dim light with placebo in the control group. This
is a 2 x 2 factorial double-blind cluster-randomized
trial comparing two light settings in several nursing
homes, with a total of 189 participants, of whom 87%
had dementia (Riemersma-van der Lek et al., 2008).
However, three trials found that Light Therapy had
no signiﬁcant effect in reducing BPSD (Ancoli-Israel
et al., 2003; Barrick et al., 2010; Burns et al., 2009;
Hickman et al., 2007), and one trial reported that the
agitation in PwDwas worsened (Barrick et al., 2010).
One of the ﬁve trials did not consider the visual
capability of PwD (Ancoli-Israel et al., 2003).
SNOEZELEN THERAPY
Snoezelen Therapy, also referred to as Multisensory
Therapy, was investigated by two trials both with
NHMRC evidence hierarchy lV (Berkheimer et al.,
Figure 3. Summary of “capability consideration” of clinical trials on interventions for BPSD in nursing home residents.
Figure 2. Summary of clinical outcomes of interventions for BPSD in nursing home residents.
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2017; van Weert et al., 2005). One trial compared
Snoezelen Therapy with Exercise Therapy for three
weeks and found that the reduction in agitation
was not signiﬁcant under both intervention types
(Berkheimer et al., 2017). The other trial integrated
SnoezelenTherapy into 24-hour care for 18months,
with each resident having a personal care plan, and
found signiﬁcant reduction in apathy, aggression,
and depression after the intervention (van Weert
et al., 2005). Snoezelen Therapy is designed with the
sensory capabilities of PwD in mind. Declines in
sensory capabilities (i.e. hearing, vision, taste, smell,
touch) are common in elderly adults, with the rate of
decline varying across senses for each person. By
stimulating a few senses together in Snoezelen Ther-
apy, a PwD with sensory impairments in less than
ﬁve senses could still receive stimuli from the ther-
apy via their remaining functional senses. According
to the guidelines for designing perceptible informa-
tion for PwD, different modes (pictorial, verbal,
tactile) should be used together to present essential
information (Mäki and Topo, 2009). Hence, all
trials applying Snoezelen Therapy have considered
sensory capabilities of PwD.
TECHNOLOGY-ASSISTED THERAPY
A Technology-Assisted Therapy is the intervention
type in which the roles of caregivers or therapists are
replaced by technologies. Five trials were found
for this intervention type. One trial explored the
effectiveness of a personalized multimedia device
(Davison et al., 2016). The device can play music
and display images, ﬁlms, and messages that were
selected or made by family members of the PwD.
This trial was of NHMRC hierarchy level II and
showed a signiﬁcant reduction in agitation in PwD
after the intervention. It also reported that assistance
was needed and offered for PwD in late stages. This
personalized multimedia device is designed with the
touch capabilities of PwD in mind. Speciﬁcally,
researchers found some PwD ﬁnd touch sensitive
icons confusing in preliminary ﬁeld testing, thus
they added traditional buttons afﬁxed to the screen
for those PwD with that preference.
Four trials examined the effectiveness of a
therapeutic robot (Joranson et al., 2015a, 2015b,
2016; Moyle et al., 2017). This robot, with an
appearance of a baby seal, was placed on the lap
of PwD. The robot generated movement and sound
mimicking the baby seal to give somatosensory and
auditory stimulations to PwD. The four trials
were of NHMRC evidence hierarchy III-1 and re-
ported that agitation and depression in PwD
were signiﬁcantly reduced with no reduction in
antipsychotic medication after the intervention.
One trial applied the robot in individual sessions
(Moyle et al., 2017), and the remaining three trials
applied the robot in group sessions (Joranson et al.,
2015a, 2015b, 2016). This robot is designed with
the sensory capabilities of PwD in mind as it stimu-
lates several senses in PwD, which is similar to
Snoezelen therapy. Therefore, all trials in this
intervention type have considered the capabilities
of PwD.
OTHER SENSORY-ORIENTED INTERVENTIONS
Three sensory-oriented interventions were evaluated
by one trial only. Animal-Assisted Therapy was
examined by a trial of NHMRC evidence hierarchy
III-1 (Olsen et al., 2016). This therapy organized
regular dog visits in a group session accompanied by
a dog handler, which found depression in PwD was
reduced signiﬁcantly after the intervention. Positive
Image Therapy was assessed by a trial of hierarchy II
(Chou et al., 2016). This therapy displayed images
preferred by PwD with voice prompt during bathing
time, which led to fewer behavioral problems. How-
ever, the sample size of this trial was too small to
calculate the signiﬁcance. Clowning Therapy was
evaluated by a trial of hierarchy IV (Kontos et al.,
2016). The elder clowns visited the nursing home
regularly to entertain the PwD for 12 weeks and
reported that BPSD was reduced signiﬁcantly after
the intervention. In the Animal-Assisted Therapy
and Clowning Therapy, several senses of PwD were
stimulated, which is similar to SnoezelenTherapy. In
the Positive Image Therapy, visual impairment was
used as an exclusion criterion in the clinical trial.
Therefore, all three trials have considered the sen-
sory capabilities of PwD.
Cognition-oriented therapy
REMINISCENCE THERAPY
Five trials examined the effectiveness of Reminis-
cence Therapy, which were all of NHMRC evidence
hierarchy level II (Haight et al., 2006; Haslam et al.,
2010; Lai et al., 2004; Politis et al., 2004; Wang,
2007). The session type, structure, duration, and
total intervention time of Reminiscence Therapy
varied across trials. The therapy has been conducted
in group or individual sessions via unstructured,
semi-structured, and structured activities. The re-
ported duration of one session ranged from 30 to 60
minutes, and the reported total intervention time
went from four to eight weeks.
Three trials showed the apathy, agitation, and
depression of PwD were signiﬁcantly reduced after
the intervention (Haight et al., 2006; Lai et al., 2004;
Politis et al., 2004), and the remaining two trials
showed the reduction was insigniﬁcant (Haslam
et al., 2010; Wang, 2007). This intervention is de-
signed with the memory and attention capabilities of
PwD in mind. In terms of memory, this intervention
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stimulates the long-term memory, which is rela-
tively intact in PwD, compared to other types of
memories. In terms of attention, this intervention
involves interactions between caregivers and PwD
to keep PwD concentrated during the intervention.
These interactions are essential as the capability of
inhibiting irrelevant information is declined in PwD.
According to the guidelines for designing for PwD,
the design should remind PwD about their previous
experiences and give feedback immediately, given
the short attention span of the PwD (Mäki and
Topo, 2009). Thus, the main cognitive capabilities
of PwD were considered in the trials.
SIMULATED PRESENCE THERAPY
Three trials investigated Simulated Presence Ther-
apy, with one trial of NHMRC evidence hierarchy
III-1 (Camberg et al., 1999) and two trials of hier-
archy IV (Cheston et al., 2007; Miller et al., 2001).
All trials applied audio recordings to simulate a
phone call from a family member of the PwD to
engage PwD in conversations.
One trial reported that the response of PwD
varied widely from dramatic reduction in distress
to apparent indifference (Cheston et al., 2007). One
trial found that some PwD recognized this phone
call is a simulation and refused to listen again (Miller
et al., 2001). One trial reported that the “interest”
subscale of Positive Affect Rating Scale was signiﬁ-
cantly increased after the intervention; however,
there was no change in BPSD (Camberg et al.,
1999).
The main cognitive capabilities of PwD were
not fully considered in the intervention. In terms
of memory, the phone call could trigger the long-
term memory of the PwD by the familiar voices.
However, in terms of attention, the interactions be-
tween PwD and the audio recordings were limited at
the audial level, and this lack of sensory engagement
could result in the PwD getting easily distracted
during the therapy. Besides, it is difﬁcult for care-
givers to check if PwD are distracted. None of the
trials have examined if PwD had the adequate capa-
bility to inhibit irrelevant information to ensure they
can concentrate throughout the therapy. Therefore,
these trials have not fully considered the main
cognitive capabilities of PwD.
OTHER COGNITION-ORIENTED INTERVENTIONS
Two cognition-oriented interventions were exam-
ined by one trial only. Cognitive Stimulation Ther-
apy was evaluated by a trial of NHMRChierarchy II,
which found apathy and depression in PwD were
reduced signiﬁcantly after the intervention (Niu
et al., 2010). Storytelling Therapy was assessed by
a trial of hierarchy III-1, which found no signiﬁcant
reduction in BPSD (Houser et al., 2014). The
Cognitive Stimulation Therapy provides cognitive
games to stimulate PwD, and its clinical trial con-
sidered the cognitive capabilities of PwD by only
including PwD in their early to moderate stage (Niu
et al., 2010). The Storytelling Therapy prompts a
group of PwD to give comments about a picture and
uses these comments to form a story, and its clinical
trial had no assessment on cognitive capabilities of
PwD participants.
Movement-oriented therapy
EXERCISE THERAPY
Five trials examined the effectiveness of Exercise
Therapy; four trials were of NHMRC evidence
hierarchy II (Hokkanen et al., 2008; Rolland et al.,
2007; Telenius et al., 2015a, 2015b) and one trial
was of hierarchy III-1 (Treusch et al., 2015). The
content of the exercise varied across trials from
intensive strengthening to dance. Ranking the inten-
sity of the exercise in these trials is difﬁcult due to the
lack of detailed exercise description in each trial.
The total intervention time ranged from 12 weeks to
12 months in these trials.
Four trials found apathy and agitation in PwD
reduced signiﬁcantly (Hokkanen et al., 2008; Tele-
nius et al., 2015a, 2015b; Treusch et al., 2015), while
one trial found no signiﬁcant reduction in BPSD
after the intervention (Rolland et al., 2007). All trials
in this intervention type considered the movement
capabilities of PwD by excluding PwDwho were not
capable to move independently with or without an
assistive device.
OUTDOOR ACTIVITY THERAPY
Four trials examined the effectiveness of Outdoor
Activity Therapy; three trials were of hierarchy IV
(Calkins et al., 2007; Luk et al., 2011; Vuolo, 2003)
and one trial was of hierarchy II (Connell et al.,
2007). The content, duration, frequency of applica-
tion, and total intervention time varied across trials.
The reported content included gardening, horticul-
tural therapy, and walking outdoors, and the dura-
tion ranged from 30 to 60 minutes. The reported
frequency of application went from daily to twice a
week, and the total intervention time spanned from
2 weeks to 12 months.
One trial found a signiﬁcant reduction in verbal
agitation in PwD (Connell et al., 2007), and one trial
reported the physically non-aggressive behavior in
PwD reduced signiﬁcantly after the intervention
(Vuolo, 2003). Two remaining trials found no sig-
niﬁcant reduction in BPSD (Calkins et al., 2007;
Luk et al., 2011). All trials considered themovement
capabilities of PwD by only including PwD who
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were capable to move independently or with an
assistive device.
Discussion
As far as we are aware from the current literature, this
is the ﬁrst study to systematically examine the effec-
tiveness of non-pharmacological interventions for
BPSD in nursing homes, with an additional assess-
ment criterion based on ergonomics, speciﬁcally,
capability consideration. The current review investi-
gated whether the capabilities of PwD were consid-
ered in the interventions and their clinical trials. The
interventions were categorized according to the
capabilities of PwD required to participate, which
are sensory-, cognition-, and movement-oriented.
The quality of evidence for the effectiveness of these
interventions is found to be low in general. Sensory-
oriented interventions have been explored and eval-
uated more than cognition- and movement-oriented
interventions, with Music Therapy being investi-
gated by the highest number of trials. In terms of
capability consideration, the sensory capabilities
have been considered less than cognitive and move-
ment capabilities, especially for auditory and olfac-
tory capabilities.
To elaborate on the capability considerations in
clinical trials, the trials satisﬁed the ﬁrst “capability
consideration” criterion were on Snoezelen Ther-
apy, Technology-Assisted Therapy, Animal-Assisted
Therapy, Clowning Therapy, and Reminiscence
Therapy. These interventions have accommodated
capability considerations in them, thus the trials on
these interventions have considered the capabilities in
PwD. For interventions without capability considera-
tions (i.e. Music Therapy, Aromatherapy, Light
Therapy, Positive Image Therapy, Simulated Pres-
ence Therapy, Cognitive Stimulation Therapy, Sto-
rytelling Therapy, Exercise Therapy and Outdoor
Activity Therapy), it is essential for trials to only
include PwD with adequate capabilities for the inter-
vention outcomes to be reliable. From this review,
clinical trials on Positive Image Therapy, Cognitive
Stimulation Therapy, and all movement-oriented
interventions have assessed the capabilities of PwD
for inclusion. Two-thirds of the clinical trials on
Music Therapy, one-ﬁfth of the clinical trials on
Light Therapy, and all clinical trials on Aromather-
apy, Simulated Presence Therapy, and Storytelling
Therapy have not assessed the capabilities of PwD
for inclusion. This lack of capability consideration
implies that not all participants might have had the
capabilities that the interventions required. For
instance, not all participants can hear the music in
a trial on Music Therapy. Consequently, the effec-
tiveness of these interventions would have been
underestimated, and, thus, a lack of capability con-
sideration could reduce the quality of a trial and
consequently lower the quality of evidence about
the corresponding intervention type.
A few factors could cause the sensory capabilities
to be considered less than cognitive and movement
capabilities. The sensory capabilities are more difﬁ-
cult to measure, and the PwD cannot actively com-
municate their sensory experiences due to their
cognitive impairments. In contrast, the remaining
cognitive capabilities of PwD are relatively well-
tracked, as they are assessed regularly to monitor
how their dementia progresses. The movement
capabilities are crucial for the safety of PwD and,
thus, were also assessed carefully in movement-
oriented interventions.
To include capabilities of PwD in designing
interventions and clinical trials, three approaches
should be considered. First, clinical trials should
include capability requirements in their in- and
exclusion criteria and indicate that the capabilities
of PwD participants were adequate to participate in
the interventions. This practice should be used as a
criterion for evaluating the quality of a trial in sys-
tematic reviews. Second, a capability proﬁle should
be created for each PwD in terms of sensory, cogni-
tion, and movement aspects. The suitable interven-
tions for a PwD can then be identiﬁed by matching
the capability proﬁle with the capability requirements
of the interventions. The capabilities of PwD can be
tracked over time with this proﬁle to identify new
interventions when the current interventions are no
longer suitable due to capability decline. This proﬁle
also helps researchers to identify suitable PwD for
clinical trials. Third, the interventions themselves
should be designed with the capabilities of PwD in
mind by incorporating design guidelines for PwD or
involving PwD in the design process. An interven-
tion with adequate capability consideration should
be able to include as many capability impairments as
possible or adapt to the remaining capabilities of
PwD. For example, bed-bound exercises could be
designed for PwD who are immobile. The third
approach is the most fundamental because some
capabilities are difﬁcult and costly to measure regu-
larly. Moreover, by designing the interventions with
capability considerations, more PwD with capability
impairments will be able to participate and, thus,
beneﬁt from the interventions. With more partici-
pants, the clinical trials on non-pharmacological
interventions for BPSD could have a larger sample
size, which could improve the quality of evidence.
Since ergonomics has a human-centered approach
and has investigated age-related capability changes,
it would facilitate the intervention design process.
Ameta-analysis is impossible due to the following
limitations of the clinical trials. Firstly, the outcomes
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have been measured by a broad range of validated
scales and physiological parameters. Over 60 scales
have been used with some scales focusing on one
aspect of BPSD (e.g., Cohen-Mansﬁeld Agitation
Inventory [Cohen-Mansﬁeld, 1997]) while other
scales measuring BPSD comprehensively (e.g.,
Neuropsychiatric Inventory [Kaufer et al., 2000]).
The physiological parameters include heart rate,
cortisol level, and skin conductance. Comparing
the outcomes of these trials is difﬁcult due to this
wide variation in measurement methods. In addi-
tion, the design of control groups varies across trials.
Some trials applied a placebo activity in the control
group (e.g., reading activity as a placebo for Music
Therapy [Cooke et al., 2010]), while most trials
applied “usual care” in the control group. “Usual
care” was not clearly described in these trials and
further hinders comparison. Moreover, some trials
have not accounted for potential confounding fac-
tors. For instance, the social interactions between
PwD might also contribute to reducing BPSD for
Music Therapy conducted in a group session (Sung
et al., 2006; Suzuki et al., 2004; van deWinckel et al.,
2004). The current study demonstrates a lack of
standardization and heterogeneity in study designs
of nonpharmacological interventions in clinical
trials of BPSD. Therefore, improving data homoge-
neity, study designs, and reporting in future clinical
trials is urgent, which is in accordance with previous
systematic reviews (Abraha et al., 2017; Brasure
et al., 2016; Cohen-Mansﬁeld, 2001).
The link between the effectiveness of non-
pharmacological interventions and their capability
considerations cannot be drawn due to the above-
mentioned limitations in clinical trials. These lim-
itations make comparisons between intervention
outcomes across clinical trials difﬁcult. A hypothesis
is that interventions that consider capabilities in
PwD are more effective than interventions that do
not. This hypothesis needs to be examined in future
clinical trials; that is, by comparing the outcome
measurements of the same intervention with and
without capability considerations. This comparison
can only be carried out when these clinical trials have
overcome the limitations.
Apart from capability considerations, treatment
parameters could also affect the effectiveness of the
interventions, such as the dose, timing, and duration
of an intervention. Cohen-Mansﬁeld stated that the
effectiveness of an interventionmay depend on these
parameters, instead of the inherent applicability of
the intervention type (Cohen-Mansﬁeld, 2001). As
treatment parameters were not commonly reported
in clinical trials, together with the abovementioned
limitations in these trials, it is impossible to conclude
on how these parameters affected the effectiveness of
an intervention, which is a remaining challenge for
future studies.
A limitation of this review is that it is only focused
on if the capabilities of the PwD are considered in
the interventions and their clinical trials. We did
not include caregiver interventions in the current
study, as the focus of the current review is on
capability considerations of PwD. The capabilities
of caregivers are also vital for the interventions to be
carried out reliably, thus to ensure high quality of
evidence. For example, if a caregiver can accomplish
the non-pharmacological intervention given the time
constraints; and if the training is adequate for the
caregiver to understand how to operate a device used
for the intervention. However, it is not common for
clinical trials to report these details, thus, the con-
sideration of the capabilities of caregivers cannot be
made in the current review. This review provides a
starting point for considering human capabilities in
non-pharmacological interventions and the subse-
quent clinical trials for BPSD in nursing homes. In
future trials, it might be worthwhile to consider the
capabilities of both PwD and caregivers. The fact
that not all interventions were truly based on capa-
bilities of PwD, and that 28 out of 64 trials did not
consider capabilities, is also a limitation of the cur-
rent review. It would be worthwhile for future stud-
ies to explore how to assess if capabilities of PwD are
truly considered.
Despite the fact that the current quality of evi-
dence is low, the evidence indicates that a wide
variety of non-pharmacological interventions for
BPSD in nursing homes have been developed and
carried out with a few reported adverse effects.
The consideration of human capabilities for antipsy-
chotic medications is not as vital as that of non-
pharmacological interventions, which indicates that
non-pharmacological interventions are more chal-
lenging to be implemented. Given their fewer
adverse effects than that of medication, future stud-
ies focusing on non-pharmacological interventions
for BPSD should include capability considerations
for PwD to gather more high-quality evidence.
Recommendations for future research
The ﬁndings lead to the following ﬁve recommen-
dations for future studies:
• Capability requirements for PwD should be
included in the in- and exclusion criteria of clinical
trials on non-pharmacological interventions
• Capability requirements should be included as a
criterion for assessing the quality of clinical trials
on non-pharmacological interventions in systematic
reviews
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• The sensory, cognition, and movement capabilities
of each PwD should be assessed regularly over time
and recorded in a proﬁle to identify suitable inter-
ventions for each PwD and ease the selection process
in clinical trials.
• Non-pharmacological interventions should be
designed with the capabilities of PwD in mind
under the guidance of ergonomics.
• Clinical trials should be conducted more sys-
tematically by establishing consensus on outcome
measurements, reﬁning study designs, developing
reporting standards, and managing confounding
factors.
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